33 citations
,
February 1996 in “Lancet” Losartan can cause temporary loss of taste.
34 citations
,
February 2023 in “Frontiers in Public Health” This meta-analysis found that hospitalized COVID-19 survivors have a significantly higher risk of experiencing long-term symptoms like dyspnea, anxiety, myalgia, and hair loss compared to those not hospitalized.
9 citations
,
February 1996 in “Lancet” In this study, reversible ageusia in a patient was strongly suggested to be caused by losartan, with potential implications for angiotensin receptor involvement in taste disturbance.
14 citations
,
January 2021 in “Cureus” This study suggests that the AndroCoV clinical scoring system may be a more sensitive and cost-effective tool for diagnosing COVID-19 compared to RT-PCR-SARS-CoV-2 tests, potentially reducing diagnostic delays and false negatives.
9 citations
,
May 2022 in “Drugs in Context” This report describes the successful use of sonidegib in treating two cases of locally advanced basal cell carcinoma, leading to remission in both instances, and reducing lesions in a patient with Gorlin syndrome, while noting mild side effects consistent with the drug's known profile.